Total Payments
$2,982
2024 Payments
$14.05
Companies
26
Transactions
196
Medicare Patients
3,273
Medicare Billing
$371,846
Payment Breakdown by Category
Food & Beverage$2,982 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,982 | 196 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $443.12 | 31 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $384.65 | 28 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $331.66 | 24 | $0 (2020) |
| Amgen Inc. | $267.57 | 15 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $241.85 | 15 | $0 (2020) |
| Radius Health, Inc. | $238.87 | 12 | $0 (2019) |
| ABBVIE INC. | $200.32 | 10 | $0 (2024) |
| Allergan, Inc. | $130.94 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $124.03 | 8 | $0 (2020) |
| Lilly USA, LLC | $97.84 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.05 | 1 | ABBVIE INC. ($14.05) |
| 2023 | $35.20 | 2 | Novo Nordisk Inc ($21.35) |
| 2022 | $64.37 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($30.05) |
| 2021 | $99.78 | 6 | Novo Nordisk Inc ($34.43) |
| 2020 | $603.33 | 43 | Novo Nordisk Inc ($124.13) |
| 2019 | $624.22 | 40 | AstraZeneca Pharmaceuticals LP ($142.55) |
| 2018 | $858.91 | 55 | Radius Health, Inc. ($142.85) |
| 2017 | $682.10 | 45 | Merck Sharp & Dohme Corporation ($176.78) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: INSOMNIA | ||||||
| 01/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Gastroenterology | ||||||
| 09/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 05/09/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 01/27/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 01/27/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Obesity | ||||||
| 01/13/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 10/26/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Virology & Specialty Care | ||||||
| 10/22/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 10/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/20/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Central Nervous System | ||||||
| 10/15/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 10/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/13/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Obesity | ||||||
| 10/07/2020 | Allergan, Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/29/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 09/21/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 756 | 1,385 | $373,484 | $97,897 |
| 2022 | 5 | 584 | 1,233 | $310,497 | $80,775 |
| 2021 | 9 | 732 | 1,369 | $263,701 | $88,529 |
| 2020 | 20 | 1,201 | 2,115 | $254,754 | $104,645 |
Total Patients
3,273
Total Services
6,102
Medicare Billing
$371,846
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 841 | $243,049 | $53,149 | 21.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 249 | 249 | $73,455 | $31,491 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 183 | $37,332 | $8,014 | 21.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 27 | 56 | $5,096 | $1,737 | 34.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 14 | $6,482 | $1,533 | 23.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 30 | $3,570 | $1,222 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,500 | $749.98 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 303 | 893 | $235,552 | $56,098 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $32,064 | $14,931 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 146 | $27,032 | $6,010 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,802 | $2,402 | 20.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 20 | 45 | $4,047 | $1,332 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 280 | 685 | $160,604 | $47,877 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 148 | 148 | $35,433 | $19,313 | 54.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 165 | 254 | $39,100 | $11,981 | 30.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 19 | 69 | $8,889 | $3,203 | 36.0% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 21 | 81 | $6,009 | $1,907 | 31.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 26 | 56 | $4,578 | $1,613 | 35.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 27 | 30 | $3,290 | $1,165 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,998 | $882.93 | 17.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 32 | 32 | $800.00 | $587.84 | 73.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 178 | 476 | $107,100 | $35,448 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 197 | 197 | $38,525 | $22,477 | 58.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 355 | $47,925 | $16,100 | 33.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 39 | 161 | $16,100 | $7,945 | 49.3% |
About Dr. James Qualls, DO
Dr. James Qualls, DO is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1407141120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Qualls, DO has received a total of $2,982 in payments from pharmaceutical and medical device companies, with $14.05 received in 2024. These payments were reported across 196 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,982).
As a Medicare-enrolled provider, Qualls has provided services to 3,273 Medicare beneficiaries, totaling 6,102 services with total Medicare billing of $371,846. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Athens, TX
- Active Since 06/10/2011
- Last Updated 05/12/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407141120
Products in Payments
- FARXIGA (Drug) $384.65
- Tymlos (Biological) $238.87
- XARELTO (Drug) $210.05
- Ozempic (Drug) $188.16
- JANUVIA (Drug) $147.77
- Saxenda (Drug) $147.53
- Aimovig (Biological) $144.15
- ENTRESTO (Drug) $95.10
- Repatha (Biological) $89.37
- XIFAXAN (Drug) $77.47
- ASMANEX (Drug) $58.25
- Creon (Drug) $56.28
- BELSOMRA (Drug) $56.27
- MYRBETRIQ (Drug) $56.06
- VRAYLAR (Drug) $45.59
- CHANTIX (Drug) $44.47
- Victoza (Drug) $43.05
- Vascepa (Drug) $41.58
- Rybelsus (Drug) $39.01
- Xofluza (Drug) $36.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681